Profiel
Alexander Nolte worked as Director-International Accounting at Aegerion Pharmaceuticals, Inc. from 2013 to 2015.
He then worked as Chief Accounting Officer & Vice President at Syndax Pharmaceuticals, Inc. from 2017 to 2023.
In 2023, he became the Chief Financial Officer, Treasurer & CAO at Oncorus, Inc. Mr. Nolte received an undergraduate degree from The Hague University of Applied Sciences.
Eerdere bekende functies van Alexander Nolte
| Bedrijven | Functie | Einde |
|---|---|---|
| ONCORUS, INC. | Director of Finance/CFO | 04-08-2023 |
| SYNDAX PHARMACEUTICALS, INC. | Director of Finance/CFO | 13-06-2022 |
| AEGERION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-07-2015 |
Opleiding van Alexander Nolte
| The Hague University of Applied Sciences | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Health Technology |
| ONCORUS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
